{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:15:39Z","timestamp":1778523339625,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272383"],"award-info":[{"award-number":["82272383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070189"],"award-info":[{"award-number":["32070189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ5341"],"award-info":[{"award-number":["2024JJ5341"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113663","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T13:01:20Z","timestamp":1734613280000},"page":"113663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hepatitis B core virus-like particles bearing Pgp3 antigen enhance immune response against genital chlamydial infection in mice"],"prefix":"10.1016","volume":"146","author":[{"given":"Xinglv","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keliang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2024.113663_b0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.idc.2023.02.007","article-title":"Update on the epidemiology, screening, and management of chlamydia trachomatis infection","volume":"37","author":"Hocking","year":"2023","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"4","key":"10.1016\/j.intimp.2024.113663_b0010","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftab012","article-title":"Immunopathogenesis of genital Chlamydia infection: insights from mouse models","volume":"79","author":"Dockterman","year":"2021","journal-title":"Pathog. Dis."},{"issue":"22","key":"10.1016\/j.intimp.2024.113663_b0015","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1128\/JB.00847-10","article-title":"Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen","volume":"192","author":"Chen","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.intimp.2024.113663_b0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2180-8-90","article-title":"Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner","volume":"8","author":"Li","year":"2008","journal-title":"BMC Microbiol."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2024.113663_b0025","article-title":"A novel chimeric recombinant FliC-Pgp3 vaccine promotes immunoprotection against Chlamydia muridarum infection in mice","volume":"258","author":"Zhao","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2024.113663_b0030","article-title":"Preparation of graphene oxide-stabilized Pickering emulsion adjuvant for Pgp3 recombinant vaccine and enhanced immunoprotection against Chlamydia Trachomatis infection","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113663_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.989620","article-title":"Chitosan particle stabilized Pickering emulsion\/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice","volume":"13","author":"Shu","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113663_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10071120","article-title":"Advances in infectious disease vaccine adjuvants","volume":"10","author":"Fan","year":"2022","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.intimp.2024.113663_b0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1473-3099(24)00147-6","article-title":"An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial","volume":"24","author":"Pollock","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0050","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41467-024-45526-2","article-title":"Immune signature of Chlamydia vaccine CTH522\/CAF\u00ae01 translates from mouse-to-human and induces durable protection in mice","volume":"15","author":"Olsen","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2024.113663_b0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","article-title":"Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?","volume":"20","author":"de la Maza","year":"2021","journal-title":"Exp. Rev. Vacc."},{"key":"10.1016\/j.intimp.2024.113663_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1342621","article-title":"Antibody responses to Chlamydia trachomatis vaccine candidate antigens in Chlamydia-infected women and correlation with antibody-mediated phagocytosis of elementary bodies","volume":"14","author":"Yu","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/btm2.10049","article-title":"Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery","volume":"2","author":"Rohovie","year":"2017","journal-title":"Bioeng. Transl. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.113663_b0070","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1021\/acsabm.1c00738","article-title":"Immunogenicity and vaccine efficacy boosted by engineering human heavy chain ferritin and chimeric hepatitis B virus core nanoparticles","volume":"4","author":"Qu","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"6","key":"10.1016\/j.intimp.2024.113663_b0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1348-0421.2009.00135.x","article-title":"Screen of multifunctional monoclonal antibodies against hepatitis B core virus-like particles","volume":"53","author":"Sun","year":"2009","journal-title":"Microbiol. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2024.113663_b0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Pumpens","year":"2001","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(98)01599-3","article-title":"Hepatitis B core particles as a universal display model: a structure-function basis for development","volume":"442","author":"Pumpens","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2024.113663_b0090","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010099","article-title":"Influenza hemagglutinin nanoparticle vaccine elicits broadly neutralizing antibodies against structurally distinct domains of H3N2 HA","volume":"8","author":"Portnoff","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12934-023-02043-z","article-title":"Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice","volume":"22","author":"Sazegari","year":"2023","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010139","article-title":"Recent progress on the versatility of virus-like particles","volume":"8","author":"Qian","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2024.113663_b0110","doi-asserted-by":"crossref","unstructured":"J. Mestecky, Z. Moldoveanu, M.W. Russell, Immunologic uniqueness of the genital tract: challenge for vaccine development, Am. J. Reprod. Immunol. (New York, N.Y. : 1989) 53(5) (2005) 208-14.","DOI":"10.1111\/j.1600-0897.2005.00267.x"},{"issue":"9","key":"10.1016\/j.intimp.2024.113663_b0115","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.4161\/hv.29683","article-title":"Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis","volume":"10","author":"Rey-Ladino","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2024.113663_b0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clim.2017.08.004","article-title":"Adjuvant formulations for virus-like particle (VLP) based vaccines","volume":"183","author":"Cimica","year":"2017","journal-title":"Clin. Immunol. (Orlando Fla.)"},{"issue":"22","key":"10.1016\/j.intimp.2024.113663_b0125","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2021.03.043","article-title":"Chlamydia trachomatis: cell biology, immunology and vaccination","volume":"39","author":"Murray","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2024.113663_b0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2020.06.024","article-title":"Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications","volume":"156","author":"Chung","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2024.113663_b0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.nano.2010.04.005","article-title":"Viral nanoparticles as platforms for next-generation therapeutics and imaging devices","volume":"6","author":"Steinmetz","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: a review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol. Biotechnol."},{"issue":"15","key":"10.1016\/j.intimp.2024.113663_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158579","article-title":"Virus-like particles: fundamentals and biomedical applications","volume":"23","author":"Mej\u00eda-M\u00e9ndez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113663_b0150","doi-asserted-by":"crossref","first-page":"e0120751","DOI":"10.1371\/journal.pone.0120751","article-title":"Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins","volume":"10","author":"Peyret","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00253-020-11012-0","article-title":"Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them","volume":"105","author":"Sani","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.113663_b0160","article-title":"The dual role of cytokine responses to Chlamydia trachomatis infection in host pathogen crosstalk","volume":"173","author":"Min","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2024.113663_b0165","doi-asserted-by":"crossref","unstructured":"M. Abu-Lubad, T.F. Meyer, M.A. Al-Zeer, Chlamydia trachomatis inhibits inducible NO synthase in human mesenchymal stem cells by stimulating polyamine synthesis, Journal of immunology (Baltimore, Md. : 1950) 193(6) (2014) 2941-51.","DOI":"10.4049\/jimmunol.1400377"},{"issue":"1","key":"10.1016\/j.intimp.2024.113663_b0170","doi-asserted-by":"crossref","first-page":"14688","DOI":"10.1038\/s41598-022-18941-y","article-title":"Aberrant gene expression of superoxide dismutases in Chlamydia trachomatis-infected recurrent spontaneous aborters","volume":"12","author":"Ray","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.113663_b0175","article-title":"The role of tryptophan in Chlamydia trachomatis persistence","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:57:12Z","timestamp":1778522232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924021854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"alternative-id":["S1567576924021854"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113663","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B core virus-like particles bearing Pgp3 antigen enhance immune response against genital chlamydial infection in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113663"}}